BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9888582)

  • 1. The molecular basis of isolated 17,20 lyase deficiency.
    Miller WL; Geller DH; Auchus RJ
    Endocr Res; 1998; 24(3-4):817-25. PubMed ID: 9888582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5.
    Geller DH; Auchus RJ; Miller WL
    Mol Endocrinol; 1999 Jan; 13(1):167-75. PubMed ID: 9892022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls in characterizing P450c17 mutations associated with isolated 17,20-lyase deficiency.
    Gupta MK; Geller DH; Auchus RJ
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4416-23. PubMed ID: 11549685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of 17,20 lyase activity.
    Miller WL; Auchus RJ; Geller DH
    Steroids; 1997 Jan; 62(1):133-42. PubMed ID: 9029728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
    Auchus RJ; Miller WL
    Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.
    Van Den Akker EL; Koper JW; Boehmer AL; Themmen AP; Verhoef-Post M; Timmerman MA; Otten BJ; Drop SL; De Jong FH
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5714-21. PubMed ID: 12466376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer.
    Auchus RJ; Lee TC; Miller WL
    J Biol Chem; 1998 Feb; 273(6):3158-65. PubMed ID: 9452426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the adrenal cytochrome P450C17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosynthesis.
    Cloutier M; Fleury A; Courtemanche J; Ducharme L; Mason JI; Lehoux JG
    DNA Cell Biol; 1997 Mar; 16(3):357-68. PubMed ID: 9115645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase.
    Lin D; Black SM; Nagahama Y; Miller WL
    Endocrinology; 1993 Jun; 132(6):2498-506. PubMed ID: 8504753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.
    Sherbet DP; Tiosano D; Kwist KM; Hochberg Z; Auchus RJ
    J Biol Chem; 2003 Dec; 278(49):48563-9. PubMed ID: 14504283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of 17alpha-hydroxylase/17,20-lyase activity of guinea pig cytochrome P450c17 by site-directed mutagenesis.
    Beaudoin C; Lavallée B; Tremblay Y; Hum DW; Breton R; de Launoit Y; Bélanger A
    DNA Cell Biol; 1998 Aug; 17(8):707-15. PubMed ID: 9726253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a unifying mechanism for CYP17 mutations that cause isolated 17,20-lyase deficiency.
    Auchus RJ; Gupta MK
    Endocr Res; 2002 Nov; 28(4):443-7. PubMed ID: 12530647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species.
    Brock BJ; Waterman MR
    Biochemistry; 1999 Feb; 38(5):1598-606. PubMed ID: 9931027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and mutagenesis of the active site of human P450c17.
    Lin D; Zhang LH; Chiao E; Miller WL
    Mol Endocrinol; 1994 Mar; 8(3):392-402. PubMed ID: 8015556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1).
    Lee SG; Kim V; Lee GH; Kim C; Jeong E; Guengerich FP; Kim D
    J Inorg Biochem; 2023 Mar; 240():112085. PubMed ID: 36640554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic and functional basis of isolated 17,20-lyase deficiency.
    Geller DH; Auchus RJ; Mendonça BB; Miller WL
    Nat Genet; 1997 Oct; 17(2):201-5. PubMed ID: 9326943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the 17 alpha-hydroxylase/C17,20-lyase activities of porcine, guinea pig and bovine P450c17 using purified recombinant fusion proteins containing P450c17 linked to NADPH-P450 reductase.
    Shet MS; Fisher CW; Tremblay Y; Belanger A; Conley AJ; Mason JI; Estabrook RW
    Drug Metab Rev; 2007; 39(2-3):289-307. PubMed ID: 17786622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The post-translational regulation of 17,20 lyase activity.
    Miller WL; Tee MK
    Mol Cell Endocrinol; 2015 Jun; 408():99-106. PubMed ID: 25224484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1.
    Gonzalez E; Guengerich FP
    J Biol Chem; 2017 Aug; 292(32):13168-13185. PubMed ID: 28684414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen biosynthesis from cholesterol to DHEA.
    Miller WL
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):7-14. PubMed ID: 12573809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.